Results 171 to 180 of about 252,519 (340)

Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype) [PDF]

, 1997
Baldwin Toye, J. Shymanski, Maria Bobrowska, W.H. Woods, K. Ramotar   +4 more
openalex   +1 more source

A case of yogurt central line‐associated bloodstream infection in a child with intestinal failure

Nutrition in Clinical Practice, EarlyView.
Abstract Central line‐associated bloodstream infections (CLABSI) are a significant cause of morbidity in children with intestinal failure (IF). Probiotic therapy is discouraged in patients with IF because of the increased risk of bacteremia with the probiotic organism.
Nasiha Rahim, Emily Keller, Ellen Wagner, Andrea Berkemeyer, Timothy Johnson, Daniel Johnson, Timothy Sentongo   +6 more
wiley   +1 more source

Performance of Various Pharmacokinetic Parameters in Predicting Vancomycin Serum Concentrations

, 2008
Kuniaki Sano, Norihiro Suzuki, Mitsuhiro Saitoh   +2 more
openalex   +2 more sources

Comparison of different phenotypic methods for detection of Vancomycin Resistant Enterococci (VRE) among clinical isolates

, 2020
Y. Valentina, S. Umadevi, S. Pramodhini
openalex   +2 more sources

A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies [PDF]

, 2014
Kadria A. Elkhodairy, Samar A. Afifi, Azza S. Zakaria   +2 more
openalex   +1 more source

Green Synthesis of ZnO Nanoparticles From Spirulina platensis: Antimicrobial and Cytotoxic Evaluation With Molecular Docking Studies

ChemistryOpen, EarlyView.
Algal‐extract‐derived ZnO nanoparticles show shape anisotropy and are bio capped by phytochemicals. These green‐synthesized NPs strongly inhibit S. aureus and K. pneumoniae biofilms. Molecular docking suggests stable binding of surface biomolecules to microbial targets, highlighting synergistic antibacterial mechanisms.
Muhammad Rizwan, Izaz Khan, Syed Sikandar Shah, Amir hamza khan, Abdurahman Hajinur Hirad, Saira Naz, Arshad Farid, Taimoor Khan, Said Hassan   +8 more
wiley   +1 more source

Vancomycin‐Resistant Enterococci: The Value of Infection Control and Antibiotic Control Policy

, 2006
Karl Heinz Weiss
openalex   +1 more source

Decrease of Vancomycin Resistance in Enterococcus faecium Isolates from Bloodstream Infections in Italy from 2003 to 2013 [PDF]

, 2015
María Del Grosso, Tommi Kärki, Fortunato D’Ancona, Annalisa Pantosti   +3 more
openalex   +1 more source

Risk of Acute Kidney Injury andClostridioides difficileInfection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin [PDF]

, 2020
Jazmin D Lee, Brett H. Heintz, Hilary J. Mosher, Daniel J. Livorsi, Jason A. Egge, Brian C. Lund   +5 more
openalex   +1 more source

Nephrocast‐V: A Deep Learning Model for the Prediction of Vancomycin Trough Concentration Using Electronic Health Record Data

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
ABSTRACT Introduction Vancomycin is a critical antibiotic for treating methicillin‐resistant Staphylococcus aureus and other gram‐positive bacterial infections, but achieving and maintaining therapeutic trough concentrations is challenging. Objectives We hypothesized that a deep learning model could accurately predict vancomycin trough concentrations 2 
Ghodsieh Ghanbari, Craig Stevens, Eliah Aronoff‐Spencer, Atul Malhotra, Shamim Nemati, Zaid Yousif   +5 more
wiley   +1 more source